Deoxynivalenol and its toxicity
Open Access
|Oct 2010References
- Bony S, Olivier-Loiseau L, Carcelen M, Devaux A. (2007). Genotoxic potential associated with low levels of the Fusarium mycotoxins nivalenol and fusarenon X in a human intestinal cell line.: 457-465.
- Coffey R, Cummins E. (2008).. Eurosis, Ghent.
- Debouck C, Haubruge E, Bollaerts P, van Bignoot D, Brostaux Y, Werry A, Rooze M. (2001). Skeletal deformities induced by the intraperitoneal administration of deoxynivalenol (vomitoxin) in mice.: 194-198.
- Doll S, Danicke S, Valenta H. (2008). Residues of deoxynivalenol (DON) in pig tissue after feeding mash or pellet diets containing low concentrations.: 727-734.
- Forsell JH, Jensen R, Tai JH, Witt M, Lin WS, Pestka JJ. (1987). Comparison of acute toxicities od deoxynivalenol (vomitoxin) and 15-acetyldeoxynivalenol in the B6C3F1 mouse.: 155-162.
- Gouze ME, Laffitte J, Rouimi P, Loiseau N, Oswald IP, Galtier P. (2006). Effect of various doses of deoxynivalenol on liver xenoblotic metabolizing enzymes in mice.: 476-483.
- Goyarts T, Danicke S, Valenta H, Ueberschar KH. (2007). Carry-over of Fusarium toxins (deoxynivalenol and zearalenone) from naturally contaminated wheat to pigs.: 369-380.
- Gray JS, Pestka JJ. (2007). Transcriptional regulation of deoxynivalenol-induced IL-8 expression in human monocytes.: 502-511.
- Hsia CC, Wu ZY, Li YS, Zhang F, Sun ZT. (2004). Nivalenol, a main Fusarium toxin in dietary foods from high-risk areas of cancer of esophagus and gastric cardia in China, induced benign and malignant tumors in mice.: 449-456.
- Huff WE, Doerr JA, Hamilton PB, Vesonder RF. (1981). Acute toxicity of vomitoxin (deoxynivalenol) in broiler-chickens.: 1412-1414.
- Hughes DM, Gahl MJ, Graham CH, Grieb SL. (1999). Overt signs of toxicity to dogs and cats of dietary deoxynivalenol.: 693-700.
- Chung YJ, Zhou HR, Pestka JJ. (2003). Transcriptional and posttranscriptional roles for p38 mitogen-activated protein kinase in upregulation of TNF-alpha expression by deoxynivalenol (vomitoxin).: 188-201.
- Iverson F, Armstrong C, Nera E, Truelove J, Fernie S, Scott P, Stapley R, Hayward S, Gunner S. (1995). Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice.: 283-306.
- Keese C, Meyer U, Valenta H, Schollenberger M, Starke A, Weber IA, Rehage J, Breves G, Danicke S. (2008). No carry over of unmetabolised deoxynivalenol in milk of dairy cows fed high concentrate proportions.: 1514-1529.
- Kinser S, Li MX, Jia QS, Pestka JJ. (2005). Truncated deoxynivalenol-induced splenic immediate early gene response in mice consuming (n-3) polyunsaturated fatty acids.: 88-95.
- Kolf-Clauw M, Castellote J, Joly B, Bourges-Abella N, Raymond-Letron I, Pinton P, Oswald IP. (2009). Development of a pig jejunal explant culture for studying the gastrointestinal toxicity of the mycotoxin deoxynivalenol: Histopathological analysis.: 1580-1584.
- Kushiro M. (2008). Effects of Milling and Cooking Processes on the Deoxynivalenol Content in Wheat.: 2127-2145.
- Madhyastha MS, Marquardt RR, Abramson D. (1994) Structure-activity-relationships and interactions among trichothecene mycotoxins as assessed by yeast bioassay.: 1147-1152.
- Manthey FA, Wolf-Hall CE, Yalla S, Vijayakumar C, Carlson D. (2004). Microbial loads, mycotoxins, and quality of durum wheat from the 2001 harvest of the Northern Plains region of the United States.: 772-780.
- Nagy CM, Fejer SN, Berek L, Molnar J, Viskolcz B. (2005). Hydrogen bondings in deoxynivalenol (DON) conformations - a density functional study.: 55-59.
- Ouyang YL, Li SG, Pestka JJ. (1996). Effects of vomitoxin (deoxynivalenol) on transcription factor NF-kappa B/Rel binding activity in murine EL-4 thymoma and primary CD4(+) T cells.: 328-336.
- Papadopoulou-Bouraoui A, Vrabcheva T, Valzacchi S, Stroka J, Anklam E. (2004). Screening survey of deoxynivalenol in beer from the European market by an enzyme-linked immunosorbent assay.: 607-617.
- Perkowski J, Chelkowski J, Wakulinski W. (1990). Deoxynivalenol and 3-acetyl-deoxynivalenol in wheat kernels and chaff with head fusariosis symptoms.: 325-328.
- Pestka JJ. (2007). Deoxynivalenol: Toxicity, mechanisms and animal health risks.: 283-298.
- Pestka JJ, Islam Z, Amuzie CJ. (2008). Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse.: 83-87.
- Pestka JJ, Smolinski AT. (2005). Deoxynivalenol: Toxicology and potential effects on humans.: 39-69.
- Pestka JJ, Zhou HR. (2000). Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (d eoxynivalenol) ingestion.: 565-575.
- Pestka JJ, Zhou HR, Moon Y, Chung YJ. (2004). Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox.: 61-73.
- Schothorst RC, Jekel AA. (2003). Determination of trichothecenes in beer by capillary gas chromatography with flame ionisation detection.: 475-479.
- Sprando RL, Collins TFX, Black TN, Olejnik N, Rorie JI, Eppley RM, Ruggles DI. (2005). Characterization of the effect of deoxynivalenol on selected male reproductive endpoints.: 623-635.
- Sugita-Konishi Y, Park BJ, Kobayashi-Hattori K, Tanaka T, Chonan T, Yoshikawa K, Kumagai S. (2006). Effect of cooking process on the deoxynivalenol content and its subsequent cytotoxicity in wheat products.: 1764-1768.
- Sugita-Konishi Y, Pestka JJ. (2001). Differential upregulation of TNF-alpha, IL-6, and IL-8 production by deoxynivalenol (vomitoxin) and other 8-ketotrichothecenes in a human macrophage model.: 619-636.
- Sun XM, Zhang XH, Wang HY, Cao WJ, Yan X, Zuo LF, Wang JL, Wang FR. (2002). Effects of sterigmatocystin, deoxynivalenol and aflatoxin G(1) on apoptosis of human peripheral blood lymphocytes in vitro'.: 145-152.
- Sypecka Z, Kelly M, Brereton P. (2004). Deoxynivalenol and zearalenone residues in eggs of laying hens fed with a naturally contaminated diet: Effects on egg production and estimation of transmission rates from feed to eggs.: 5463-5471.
- Tajima O, Schoen ED, Feron VK, Groten JP. (2002). Statistically designed experiments in a tiered approach to screen mixtures of Fusarium mycotoxins for possible interactions.: 685-695.
- Ueno Y. (1985). The toxicology of mycotoxins.: 99-132.
- Ueno Y. (1988). Toxicology of trichothecene mycotoxins.: 121-124.
- Uzarski RL, Islam Z, Pestka JJ. (2003). Potentiation of trichothecene-induced leukocyte cytotoxicity and apoptosis by TNF-alpha and Fas activation.: 105-119.
- Vandenbroucke V, Croubels S, Verbrugghe E, Boyen F, De Backer P, Ducatelle R, Rychlik I, Haesebrouck F, Pasmans F. (2009). The mycotoxin deoxynivalenol promotes uptake of Salmonella Typhimurium in porcine macrophages, associated with ERK1/2 induced cytoskeleton reorganization.: Art. No. 64.
- Visconti A, Haidukowski EM, Pascale M, Silvestri M. (2004). Reduction of deoxynivalenol during durum wheat processing and spaghetti cooking.: 181-189.
- Wong SS, Zhou HR, Pestka JJ. (2002). Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappa B, and NF-IL6 in raw 264.7 macrophage cells.: 1161-1180.
- Yang GH, Li S, Pestka JJ. (2000). Down-regulation of the endoplasmic reticulum chaperone GRP78/BiP by vomitoxin (Deoxynivalenol).: 207-217.
- Yazar S, Omurtag G. (2008). Fumonisins, Trichothecenes and Zearalenone in Cereals.: 2062-2090.
- Yoshizawa T, Morooka N. (1973). Deoxynivalenol and its monoacetate - New mycotoxins from Fusarium-roseum and moldy barley.: 2933-2934.
- Yoshizawa T, Takeda H, Ohi T. (1983). Structure of a novel metabolite from deoxynivalenol, a trichothecene mycotoxin, in animals.: 2133-2135.
- Zhou HR, Islam Z, Pestka JJ. (2005). Induction of competing apoptotic and survival signaling pathways in the macrophage by the ribotoxic trichothecene deoxynivalenol.: 113-122.
Language: English
Page range: 94 - 99
Published on: Oct 22, 2010
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2010 Pavlina Sobrova, Vojtech Adam, Anna Vasatkova, Miroslava Beklova, Ladislav Zeman, Rene Kizek, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.